Notice2023-24343
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 3, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 212 (Friday, November 3, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 212 (Friday, November 3, 2023)]
[Notices]
[Pages 75594-75595]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-24343]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-23AX]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Assessing Knowledge, Attitudes, and
Practices (KAPs) of Hispanic/Latina Women of Reproductive Age (WRA)
about Folic Acid Fortification and Supplementation'' to the Office of
Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on November 22, 2022, to obtain comments from
the public and affected agencies. CDC received one comment related to
the previous notice. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Assessing Knowledge, Attitudes, and Practices (KAPs) of Hispanic/
Latina Women of Reproductive Age (WRA) about Folic Acid Fortification
and Supplementation--New--National Center on Birth Defects and
Developmental Disabilities (NCBDDD), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Consuming 400 micrograms (mcg) of folic acid daily in the
periconceptional period can reduce the risk of having a pregnancy
affected by a neural tube defect (NTD), a severe birth defect of the
brain and spine. To increase the amount of folic acid consumed in the
U.S. population, the U.S. Food and Drug Administration (FDA) mandated
fortification of enriched cereal grain products with folic acid in
1998. Although strides have been made in preventing neural tube
defects, ethnic disparities remain. Hispanic women in the U.S. have the
highest risk of having a child affected by a NTD, with birth prevalence
of approximately seven NTDs per 10,000 live births. In addition, prior
studies have found that Hispanic women: (1) have lower levels of folate
in their blood compared to non-Hispanic white women; (2) are more
likely than non-Hispanic white and non-Hispanic black women to have the
MTHFR C677T gene variant; (3) are less likely to know about the
benefits of folic acid; and (4) are less likely to get folic acid from
fortified foods or take a multivitamin with folic acid in it,
particularly those women who primarily speak Spanish, were born outside
of the United States, and have lived in the United States for a shorter
period of time.
To effectively reach Hispanic women of reproductive age (WRA) and
increase their knowledge and intake of folic acid for NTD prevention, a
contemporary understanding of cultural factors in the decision-making
process and how these women obtain information is needed. Previous
research highlighted important nuances in potential cultural beliefs
regarding folic acid. A study of Spanish-speaking Hispanic women in the
southwest U.S. found no cultural barriers to incorporating folic-acid
rich foods into their diets; however, focus groups of Mexican American
women did find several cultural barriers. These included: (1)
misperceptions of the term folic acid as an illegal substance, as the
word ``acid'' is like LSD; (2) its importance for NTD prevention since
their healthcare providers did not talk to them about folic acid; (3)
its absence in injectable form at the pharmacy; and (4) mistaken belief
that birth defects are not preventable (resulting from an act of
[[Page 75595]]
God). Studies have found contradictory findings, suggesting that
Mexican American women have increased awareness of the association
between folate and birth defects compared to English-speaking women.
More research is needed to determine cultural factors in the decision-
making process around folic acid intake for Hispanic WRA, though
several studies have examined beliefs and best practices for promoting
folic acid consumption.
The purpose of this project is to conduct formative research with
Hispanic/Latina women of reproductive age to examine folic acid and
fortified food awareness, food and supplement use practices, as well as
messaging and channels to reach Hispanic/Latina women. The resulting
data are expected to be used for developing new messaging and
communication products to improve knowledge, awareness, and practices
regarding folic acid fortification and supplementation among Hispanic/
Latina women of reproductive age. Additionally, the findings from the
project will inform future intervention activities to prevent neural
tube defects among Hispanic women of reproductive age.
This information collection will involve focus groups with
Hispanic/Latina WRA. CDC requests OMB approval for an estimated 122
annual burden hours. There are no costs to respondents other than their
time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Hispanic/Latina Women of Knowledge, Attitudes, and 81 1 90/60
Reproductive Age (WRA). Practices (KAPs) of
Hispanic/Latina Women of
Reproductive Age: Focus
Group Moderator Guide
(English/Spanish).
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2023-24343 Filed 11-2-23; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on November 3, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.